UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Daewoong’s diabetes therapy proves superior blood-sugar-lowering effect to existing drugs’
Daewoong Pharmaceutical said its poster session on phase 1 clinical trial o...
by Lee Han-soo
|
2019-09-20 17:51
라인
Dongwha could lose ₩60 billion sales as GSK ends deal
Dongwha Pharmaceutical faces a steep decrease in sales as GSK Consumer Heal...
by Lee Han-soo
|
2019-09-20 14:28
라인
Novo Nordisk releases trial result for basal insulin analog injection
Novo Nordisk said it has presented the global head-to-head trial called CON...
by Lee Han-soo
|
2019-09-20 12:27
라인
Multinational pharmaceuticals continue to increase R&D spending in Korea
The Korea Research-based Pharma Industry Association (KRPIA) said that the ...
by Lee Han-soo
|
2019-09-19 17:15
라인
Hanmi unveils strong diabetes pipeline at EU meet
Hanmi Pharmaceutical said that it has confirmed the global competitiveness ...
by Lee Han-soo
|
2019-09-19 15:30
라인
Rayence launches low-dose, high-performance X-ray detector
Rayence said Thursday that it has developed a Super IGZO-based high-speed v...
by Lee Han-soo
|
2019-09-19 15:29
라인
Chong Kun Dang releases trial result for diabetes treatment
Chong Kun Dang said that it has presented a clinical trial result, which it...
by Lee Han-soo
|
2019-09-19 14:11
라인
'Multiple sclerosis show more severe symptoms in young people'
Researchers at Seoul National University Hospital have found young patients...
by Lee Han-soo
|
2019-09-18 18:05
라인
Ono Pharma, BMS unveil two P3 trial analyses for Opdivo
Ono Pharmaceutical and Bristol-Myers Squibb have presented pooled data on t...
by Lee Han-soo
|
2019-09-18 15:48
라인
Macrogen, Psomagen win patent for blockchain technology in US
Macrogen and Psomagen said that they have registered a patent for its block...
by Lee Han-soo
|
2019-09-18 14:36
라인
Korea narrows pharmaceutical trade gap in 5 years
Korea's deficit in pharmaceuticals trade has been on the decline for th...
by Lee Han-soo
|
2019-09-18 11:38
라인
CJ Healthcare to export gastroesophageal reflux treatment to Indonesia
CJ Healthcare said that it plans to export K-CAB (Ingredient: tegoprazan), ...
by Lee Han-soo
|
2019-09-18 11:37
라인
Hanmi spurs new immunotherapy development through open innovation
Hanmi Pharmaceutical said it is launching new development projects in the f...
by Lee Han-soo
|
2019-09-17 18:14
라인
Regulator finds no trace of carcinogen in GSK’s heartburn drug
The Ministry of Food and Drug Safety said that it has failed to find the tr...
by Lee Han-soo
|
2019-09-17 16:27
라인
Shinpoong's malaria treatment expands global presence
Shinpoong Pharmaceutical said that Pyramax, its malaria treatment, is quick...
by Lee Han-soo
|
2019-09-17 15:13
라인
Noom, NCC to jointly research total healthcare for cancer patients
Noom Korea said that that it would conduct joint research with the National...
by Lee Han-soo
|
2019-09-17 11:28
라인
SK Bioscience to export influenza vaccine to Asian countries
SK Bioscience will export 250,000 doses of Skycellflu, the first cell-cultu...
by Lee Han-soo
|
2019-09-17 11:27
라인
Gyeongsang National University develops early dementia detection kit
Researchers at Gyeongsang National University have developed a kit that can...
by Lee Han-soo
|
2019-09-16 18:05
라인
Myongji Hospital to hold international liver symposium
Myongji Hospital said that it plans to hold its fourth annual "Myongji Inte...
by Lee Han-soo
|
2019-09-16 17:42
라인
'Roche Korea to put patient accessibility first'
Roche Korea, the number one company in the domestic anticancer market, is l...
by Lee Han-soo
|
2019-09-16 15:41
-
이전
31
32
33
34
35
36
37
38
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top